☆ 4.8 Letter

Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Journal

NEW ENGLAND JOURNAL OF MEDICINE

Volume 354, Issue 23, Pages 2514-2515

Publisher

MASSACHUSETTS MEDICAL SOC

DOI: 10.1056/NEJMc053129

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.